Online inquiry

IVTScrip™ mRNA-Human ASCC1, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A))   (CAT#: GTTS-WK26902MR)

This product GTTS-WK26902MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 1 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the ASCC1 protein. This product can be used in Mitotic arrest phase fetal germ cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 1
Species Human
RefSeq NM_001198798.2
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 51008
UniProt ID Q8N9N2
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ASCC1, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) (GTTS-WK26902MR). Click the button above to contact us or submit your feedback about this product.

See other products
CAT Product Name Product Type CDs
GTTS-WK14860MR IVTScrip™ mRNA-Human AMPH, (Cap 0, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA AMPH
GTTS-WK12531MR IVTScrip™ mRNA-Human ADGB, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ADGB
GTTS-WK18513MR IVTScrip™ mRNA-Human ANKRD27, (Cap 1, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA ANKRD27
GTTS-WK24511MR IVTScrip™ mRNA-Human ASGR2, (Cap 0, 2-Thio-UTP, 30 nt-poly(A)) mRNA ASGR2
GTTS-WK18537MR IVTScrip™ mRNA-Human ANKRD9, (Cap 1, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA ANKRD9
GTTS-WK28583MR IVTScrip™ mRNA-Human ARHGAP15, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ARHGAP15
GTTS-WK27757MR IVTScrip™ mRNA-Human ARMC8, (Cap 1, 5-Methoxy-UTP, 30 nt-poly(A)) mRNA ARMC8
GTTS-WK17899MR IVTScrip™ mRNA-Human ANKRD12, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ANKRD12
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
webinar

EABR Nanoparticles as a Platform Technology for Hybrid mRNA Vaccine Development

November 20th, 2024, 2 PM–3 PM EST

REGISTER NOW